Kelli Mari Howell's Insider Trades & SAST Disclosures

Kelli Mari Howell's most recent trade in Alphatec Holdings Inc was a trade of 6,050 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on Aug. 5, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alphatec Holdings Inc
Kelli Mari Howell EVP, CLINICAL STRATEGIES Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.03 per share. 05 Aug 2022 6,050 540,098 (0%) 0% 8.0 48,582 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.94 per share. 18 Mar 2022 2,940 544,114 (0%) 0% 10.9 32,164 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2022 30,655 547,054 (0%) 0% 0 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2022 25,000 516,399 (0%) 0% 0 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. 05 Aug 2021 6,050 491,399 (0%) 0% 15.2 92,142 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. 17 May 2021 17,525 497,449 (0%) 0% 14.8 259,545 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.33 per share. 29 Apr 2021 11,474 512,467 (0%) 0% 16.3 187,370 Common Stock
Alphatec Holdings Inc
Kelli Mari Howell EVP, Clinical Strategies Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2021 20,000 523,941 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades